Literature DB >> 10779266

Incidence and survival characteristics of retinoblastoma in Singapore from 1968-1995.

S M Saw1, N Tan, S B Lee, K G Au Eong, K S Chia.   

Abstract

PURPOSE: To describe the incidence and survival of 69 Singapore residents with retinoblastoma in all Singapore hospitals from 1968-1995.
METHODS: Data of all Singapore residents diagnosed with retinoblastoma from 1968-1995 were collected by the Singapore Cancer Registry based on notifications from physicians, pathology records, hospital discharge records, and death certificates. The medical records of 46 patients were traced, and information on laterality of tumor, spread of tumor, mode of treatment, and family history of retinoblastoma was obtained. Time trends and survival characteristics of the cohort were described.
RESULTS: The incidence rate of retinoblastoma was 2.4 per 1 million for children <9 years and 11.1 per 1 million for children <5 years. The incidence of retinoblastoma has been almost uniform over time from 1968-1995, except for an apparent increase in 1988-1992. The 3-year survival rate for retinoblastoma was 83%. Survival rates were higher in children <2 years because children who present at a younger age may have tumors diagnosed at earlier stages of the disease. There was no difference in survival rates for sex, race, laterality, family history of retinoblastoma, treatment, or year of diagnosis.
CONCLUSION: Retinoblastoma is the most common eye cancer in children that may cause blindness or death. The incidence rates of retinoblastoma in Singapore have remained fairly stable over 28 years, and the survival rate is higher in younger children. This study will be helpful in monitoring future disease patterns in Asian populations.

Entities:  

Mesh:

Year:  2000        PMID: 10779266     DOI: 10.3928/0191-3913-20000301-07

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  6 in total

1.  Compliance in retinoblastoma.

Authors:  Sameer Bakhshi; Shikha Gupta; Varun Gogia; Yaddanapuddi Ravindranath
Journal:  Indian J Pediatr       Date:  2010-03-19       Impact factor: 1.967

2.  Retinoblastoma in Taiwan: survival rate and prognostic factors.

Authors:  Chia-Yau Chang; Tzeon-Jye Chiou; Betau Hwang; Li-Yuan Bai; Wen-Ming Hsu; Yuh-Lin Hsieh
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

3.  A multicentre report from the Mexican Retinoblastoma Group.

Authors:  C Leal-Leal; M Flores-Rojo; A Medina-Sansón; F Cerecedo-Díaz; S Sánchez-Félix; O González-Ramella; F Pérez-Pérez; R Gómez-Martínez; A Quero-Hernández; E Altamirano-Alvarez; F Alejo-González; J Figueroa-Carbajal; A Ellis-Irigoyen; I Tejocote-Romero; R Cervantes-Paz; F Pantoja-Guillén; L Vega-Vega; F Carrete-Ramírez
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

4.  Incidence and survival of retinoblastoma in Taiwan: a nationwide population-based study 1998-2011.

Authors:  Su-Yin Li; Solomon Chih-Cheng Chen; Ching-Fang Tsai; Shew-Meei Sheu; Jun-Jun Yeh; Chong-Bin Tsai
Journal:  Br J Ophthalmol       Date:  2015-09-14       Impact factor: 4.638

5.  Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling.

Authors:  Swati Tomar; Raman Sethi; Gangadhara Sundar; Thuan Chong Quah; Boon Long Quah; Poh San Lai
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

6.  Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017.

Authors:  Michał S Nowak; Bożena Romanowska-Dixon; Iwona Grabska-Liberek; Michał Żurek
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.